Investors
IR Events
Roche’s Analyst Event at ASCO 2019
Agenda
Welcome
ASCO 2019 Key readouts across tumor types
Roche Oncology strategy update
Q&A
Karl Mahler, Head of Investor Relations
Hematology Nancy Valente, M.D., Global Head of Product Development - Hematology Breast cancer, lung cancer & pan-tumor Alan Sandler, M.D., Global Head of Product Development - Solid Tumors
Bill Anderson, CEO Roche Pharmaceuticals

Please register to access the replay*

*Privacy notice

Confirm you are a human *
The test requires you to consent to targeting cookies

Roche has hosted an analyst briefing to discuss data presented on the Roche Group’s oncology products and pipeline at the American Society of Clinical Oncology Annual Meeting (ASCO) in Chicago (1 – 5 June 2018).

Investors
Past IR Events
View more Events

Downloads

Investor presentation

PDF

Related links